DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

10.16 0.16 (1.60%)

REAL-TIME: Last trade at

Extended Hours: $10.40 $0.24 (2.36%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

ACHN $10.16 1.60%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.01
Previous Close $10.00
Daily Range $9.85 - $10.30
52-Week Range $2.45 - $16.87
Market Cap $1.2B
P/E Ratio -14.29
Dividend (Yield) $0.00 (0.0%)
Volume 2,343,666
Average Daily Volume 4,672,478
Current FY EPS -$0.97




Drug Makers


A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website:

News & Commentary

3 Things You Need to Know About Achillion Pharmaceuticals Inc.

Achillion Pharmaceuticals has a big opportunity in hepatitis C, but it also faces some risks.

Gilead's Hepatitis C Drug Sovaldi Gets Approval in Japan - Analyst Blog

Achillion And The Importance Of Hitting The Sweet Spot

Achillion Pharmaceuticals' HCV Treatments Are Worth The Investment

'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets

Why I'm Not Giving Up on This Tiny Biotech Stock (Yet)

Achillion Pharmaceuticals Inc. is working on a promising hepatitis C therapy that could reduce treatment times.

Express Scripts Issues Report on Prescription Drug Spending - Analyst Blog

Express Scripts Issues Report on Prescription Drug Spending - Analyst Blog

Should You Sell Achillion Pharmaceuticals (ACHN) Before Earnings? - Tale of the Tape

Achillion Pharmaceuticals (ACHN) Stock Tanking Today on Heavy Volume

Barclays Expands Coverge To 7 New Biotech Stocks

See More ACHN News...

ACHN's Top Competitors

ACHN $10.16 (1.60%)
Current stock: ACHN
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB